S Verstraete1, I Vanhorebeek1, A Covaci2, F Güiza1, G Malarvannan2, P G Jorens2,3, G Van den Berghe4. 1. Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. 2. Toxicology Center, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium. 3. Department of Critical Care Medicine, Antwerp University Hospital, University of Antwerp, Wilrijkstraat 10, 2650, Edegem, Belgium. 4. Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. greet.vandenberghe@med.kuleuven.be.
Abstract
PURPOSE: Environmental phthalate exposure has been associated with attention deficit disorders in children. We hypothesized that in children treated in the pediatric intensive care unit (PICU), circulating phthalates leaching from indwelling medical devices contribute to their long-term attention deficit. METHODS: Circulating plasma concentrations of di(2-ethylhexyl)phthalate (DEHP) metabolites were quantified in 100 healthy children and 449 children who had been treated in PICU and were neurocognitively tested 4 years later. In a development patient cohort (N = 228), a multivariable bootstrap study identified stable thresholds of exposure to circulating DEHP metabolites above which there was an independent association with worse neurocognitive outcome. Subsequently, in a second patient cohort (N = 221), the observed independent associations were validated. RESULTS: Plasma concentrations of DEHP metabolites, which were virtually undetectable [0.029 (0.027-0.031) µmol/l] in healthy children, were 4.41 (3.76-5.06) µmol/l in critically ill children upon PICU admission (P < 0.001). Plasma DEHP metabolite concentrations decreased rapidly but remained 18 times higher until PICU discharge (P < 0.001). After adjusting for baseline risk factors and duration of PICU stay, and further for PICU complications and treatments, exceeding the potentially harmful threshold for exposure to circulating DEHP metabolites was independently associated with the attention deficit (all P ≤ 0.008) and impaired motor coordination (all P ≤ 0.02). The association with the attention deficit was confirmed in the validation cohort (all P ≤ 0.01). This phthalate exposure effect explained half of the attention deficit in post-PICU patients. CONCLUSIONS: Iatrogenic exposure to DEHP metabolites during intensive care was independently and robustly associated with the important attention deficit observed in children 4 years after critical illness. Clinicaltrials.gov identifier: NCT00214916.
PURPOSE: Environmental phthalate exposure has been associated with attention deficit disorders in children. We hypothesized that in children treated in the pediatric intensive care unit (PICU), circulating phthalates leaching from indwelling medical devices contribute to their long-term attention deficit. METHODS: Circulating plasma concentrations of di(2-ethylhexyl)phthalate (DEHP) metabolites were quantified in 100 healthy children and 449 children who had been treated in PICU and were neurocognitively tested 4 years later. In a development patient cohort (N = 228), a multivariable bootstrap study identified stable thresholds of exposure to circulating DEHP metabolites above which there was an independent association with worse neurocognitive outcome. Subsequently, in a second patient cohort (N = 221), the observed independent associations were validated. RESULTS: Plasma concentrations of DEHP metabolites, which were virtually undetectable [0.029 (0.027-0.031) µmol/l] in healthy children, were 4.41 (3.76-5.06) µmol/l in critically ill children upon PICU admission (P < 0.001). Plasma DEHP metabolite concentrations decreased rapidly but remained 18 times higher until PICU discharge (P < 0.001). After adjusting for baseline risk factors and duration of PICU stay, and further for PICU complications and treatments, exceeding the potentially harmful threshold for exposure to circulating DEHP metabolites was independently associated with the attention deficit (all P ≤ 0.008) and impaired motor coordination (all P ≤ 0.02). The association with the attention deficit was confirmed in the validation cohort (all P ≤ 0.01). This phthalate exposure effect explained half of the attention deficit in post-PICU patients. CONCLUSIONS: Iatrogenic exposure to DEHP metabolites during intensive care was independently and robustly associated with the important attention deficit observed in children 4 years after critical illness. Clinicaltrials.gov identifier: NCT00214916.
Authors: Dirk Vlasselaers; Ilse Milants; Lars Desmet; Pieter J Wouters; Ilse Vanhorebeek; Ingeborg van den Heuvel; Dieter Mesotten; Michael P Casaer; Geert Meyfroidt; Catherine Ingels; Jan Muller; Sophie Van Cromphaut; Miet Schetz; Greet Van den Berghe Journal: Lancet Date: 2009-01-26 Impact factor: 79.321
Authors: Stephanie M Engel; Amir Miodovnik; Richard L Canfield; Chenbo Zhu; Manori J Silva; Antonia M Calafat; Mary S Wolff Journal: Environ Health Perspect Date: 2010-01-08 Impact factor: 9.031
Authors: Chao-Yu Shen; Jun-Cheng Weng; Jeng-Dau Tsai; Pen-Hua Su; Ming-Chih Chou; Shu-Li Wang Journal: Int J Environ Res Public Health Date: 2021-04-30 Impact factor: 3.390
Authors: Elena Colicino; Erik de Water; Allan C Just; Esmeralda Navarro; Nicolo Foppa Pedretti; Nia McRae; Joseph M Braun; Lourdes Schnaas; Yanelli Rodríguez-Carmona; Carmen Hernández; Marcela Tamayo-Ortiz; Martha M Téllez-Rojo; Andrea L Deierlein; Antonia M Calafat; Andrea Baccarelli; Robert O Wright; Megan K Horton Journal: Environ Res Date: 2021-05-26 Impact factor: 8.431
Authors: Shen-Che Hung; Ting-I Lin; Jau-Ling Suen; Hsien-Kuan Liu; Pei-Ling Wu; Chien-Yi Wu; Yu-Chen S H Yang; San-Nan Yang; Yung-Ning Yang Journal: Int J Environ Res Public Health Date: 2021-05-26 Impact factor: 3.390
Authors: J William Gaynor; Richard F Ittenbach; Antonia M Calafat; Nancy B Burnham; Asa Bradman; David C Bellinger; Frederick M Henretig; Erin E Wehrung; J Laurenson Ward; William W Russell; Thomas L Spray Journal: Ann Thorac Surg Date: 2018-07-30 Impact factor: 5.102